Moreover, MMSET interacts with NF-κB directly to activate the expression of NF-κB target genes (including interleukin-6, vascular endothelial growth factor A, cyclin D, Bcl-2 and Survivin) in prostate cancer cells [19]. Here, BCL2 is linked to prostate cancer.